Sagimet Biosciences (SGMT) Accounts Payables (2023 - 2024)
Sagimet Biosciences (SGMT) has 2 years of Accounts Payables data on record, last reported at $1.2 million in Q3 2024.
- For Q3 2024, Accounts Payables fell 32.31% year-over-year to $1.2 million; the TTM value through Sep 2024 reached $1.2 million, down 32.31%, while the annual FY2023 figure was $186000.0, N/A changed from the prior year.
- Accounts Payables reached $1.2 million in Q3 2024 per SGMT's latest filing, down from $2.0 million in the prior quarter.
- Across five years, Accounts Payables topped out at $2.7 million in Q2 2023 and bottomed at $186000.0 in Q4 2023.